Field

Field. Means the treatment of Duchenne Muscular Dystrophy.

Field. Means the Licensed Field as such term is defined in the License Agreement.

Field. The term 'Field' shall mean the prevention, treatment or amelioration of a specific disease, symptom, state of health, or medical- or health-related condition in humans and/or animals utilizing Nicotinamide Riboside or any NAD+ precursors limited to the patent in Exhibit B for the treat of breast cancer.

Field. The THERAPEUTIC FIELD OF USE, the THERANOSTIC FIELD OF USE, or the INTERNAL RESEARCH FIELD OF USE, where such FIELDS are further defined as: A. "THERAPEUTIC FIELD" means the use of genetically modified prokaryotic organisms to treat and/or prevent disease, disorders and/or conditions by: (1) in vivo delivery of such prokaryotic organisms to a subject; or (2) treatment of a subject's sample by ex vivo contact with such genetically modified prokaryotic organisms coupled with a subsequent in vivo... delivery to said subject of at least a portion of the treated sample or by-product thereof, and for the avoidance of any doubt expressly excludes: (a) the use of such genetically modified prokaryotic organisms to manufacture biologic agents (e.g., peptide, protein, antibody or nucleic acid) for commercialization; (b) any manufacture (including making, having made, using selling, offering for sale or importing) of diagnostic products using genetically modified prokaryotic organisms; (c) any exclusive right to conduct research and/or development; and (d) any right to exclude others from the manufacture (make and have made), use, sale, offer for sale or importation of RESEARCH TOOLS. For the avoidance of doubt, this Section 1.5(A)(d) shall not limit COMPANY's ability to exclusively practice the PATENT RIGHTS in the FIELDS licensed hereunder. B. "THERANOSTIC FIELD" means the use of a LICENSED PRODUCT to sense or report how a THERAPEUTIC LICENSED PRODUCT affects the in vivo environment and/or disease condition. For the avoidance of doubt, the THERANOSTIC FIELD expressly excludes the use of a LICENSED PRODUCT to (1) diagnose a disease or condition or (2) predict the course of a disease or condition which is not being treated by a THERAPEUTIC LICENSED PRODUCT. C. "INTERNAL RESEARCH FIELD" means the practice of the PATENT RIGHTS or use of a RESEARCH TOOL for COMPANY's internal research and development. View More

Field. Shall mean any use of Products for the treatment of Methicillin-resistant Staphylococcus Aureus (MRSA) infections in humans with cystic fibrosis and/or other pulmonary disorders where the AeroVanc dry powder formulation is utilized.

Field. All uses other than the commercial sale or use as a research reagent, including in a kit format, for research or educational purposes, including without limitation, (i) internal and collaborative use; (ii) all therapeutic and prophylactic uses; and (iii) diagnostic uses for purposes of therapeutic monitoring, but excluding all other diagnostic uses, specifically including human and veterinary diseases, for all indications.

Field. Means preparation and use of mononuclear cells (MNC) for intramyocardial injection of mononuclear cells (MNC).

Field. The development, marketing and commercialization of Tecogen's harmful emissions reduction technology for all types engines, gasoline, hybrid, diesel or natural gas-powered, but only those that are designed for, and intended to be used in, automobiles and trucks (excluding those that are designed for, and intended to be used in, fork lift trucks) or another mobile platform

Field. The prevention or treatment of any ophthalmic disease, state or condition in humans.

Field. The use of sensors and their associated hardware, software, or signal processing technology to characterize cannabis or to detect or to quantify compounds in cannabis except for applications in law enforcement